Stocks Were Just Test: How AI Stocks Fared This Year
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
Index funds carry risks for retirees, including sequence of returns and drawdown volatility. Learn strategies to mitigate these concerns.
22,186 articlesAI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
A single wall street analyst thinks Tilray could deliver a sizable rally in the coming weeks. This article breaks dow...
When Oshkosh released its latest results, the focus quickly shifted to a sharp stock move. This guide explains what h...
Investors are weighing NuScale Power as the small modular reactor (SMR) pioneer. This guide breaks down factors that ...
Sharplink's 2026 earnings path hinges on user growth, margins, and regulatory resilience. This guide breaks down the ...
Ambiq Micro is navigating a crowded IoT market with its ultra-low power chips. This article breaks down what to expec...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
As AI deployment accelerates, investors are racing into energy stocks, naming a cluster of seven top names the munifi...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Fantasy Top captivated Crypto Twitter with a fresh take on fantasy sports powered by blockchain. Now, after two years...